CIK 0001160308
- Non-accelerated filer
- Smaller reporting company
Savara Inc
Sign in to watch- Ticker
- SVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841318182
- Phone
- +51 285113796
- Business address
- 6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
- Former names
- Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-08-02 | Lowrance David L Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2018-06-12 | Neville Robert N Chief Executive Officer | Sale | −13,445 | $12.09 | $163K | 474,511 |
| 2018-06-12 | Lowrance David L Chief Financial Officer | Sale | −3,900 | $12.08 | $47K | 18,480 |
| 2018-06-12 | Jouhikainen Jaakko Taneli | Sale | −13,494 | $12.10 | $163K | 192,569 |
| 2018-06-11 | Neville Robert N Chief Executive Officer | Exercise or conversion | +92,351 | $0.65 | $60K | 494,999 |
| 2018-06-11 | Neville Robert N Chief Executive Officer | Shares withheld for taxes | −5,252 | $11.43 | $60K | 489,747 |
| 2018-06-11 | Neville Robert N Chief Executive Officer | Sale | −1,791 | $12.01 | $22K | 487,956 |
| 2018-06-11 | Neville Robert N Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −92,351 | 0 | ||
| 2018-06-11 | Lowrance David L Chief Financial Officer | Sale | −700 | $12.05 | $8K | 22,380 |
| 2018-06-11 | Jouhikainen Jaakko Taneli | Sale | −1,625 | $12.02 | $20K | 206,063 |
| 2018-06-08 | Neville Robert N Chief Executive Officer | Sale | −2,737 | $12.13 | $33K | 402,648 |
| 2018-06-08 | Lowrance David L Chief Financial Officer | Sale | −675 | $12.13 | $8K | 23,080 |
| 2018-06-08 | Jouhikainen Jaakko Taneli | Sale | −2,638 | $12.11 | $32K | 207,688 |
| 2018-03-29 | PIKOVER YURI Director | Purchase | +3,734 | $9.00 | $34K | 153,734 |
| 2018-02-15 | Neville Robert N Chief Executive Officer | Sale | −15,524 | $12.84 | $199K | 414,861 |
| 2018-02-15 | Neville Robert N Chief Executive Officer | Sale | −9,476 | $13.08 | $124K | 405,385 |
| 2018-02-15 | Jouhikainen Jaakko Taneli | Sale | −16,110 | $12.75 | $205K | 219,216 |
| 2018-02-15 | Jouhikainen Jaakko Taneli | Sale | −8,890 | $13.05 | $116K | 210,326 |
| 2018-02-15 | Lowrance David L Chief Financial Officer | Sale | −4,936 | $12.70 | $63K | 25,819 |
| 2018-02-15 | Lowrance David L Chief Financial Officer | Sale | −2,064 | $13.30 | $27K | 23,755 |
Page 18 of 20 · 390 trades